Grace Therapeutics
GRCE
6 hedge funds and large institutions have $1.11M invested in Grace Therapeutics in 2013 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
11,020% more capital invested
Capital invested by funds: $10K → $1.11M (+$1.1M)
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
50% more funds holding
Funds holding: 4 → 6 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$891K |
| 2 |
PA
Perceptive Advisors
New York
|
+$479K |
| 3 |
U
UBS
Zurich,
Switzerland
|
+$5.95K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$2.98K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of Montreal
Toronto,
Ontario, Canada
| $681K | +$891K | +599 | New |
|
|
PA
2
Perceptive Advisors
New York
| $366K | +$479K | +322 | New |
|
|
VKH
3
Virtu KCG Holdings
New York
| $53K | +$68.4K | +46 | New |
|
|
4
Royal Bank of Canada
Toronto,
Ontario, Canada
| $5K | +$2.98K | +2 | +100% |
|
|
U
5
UBS
Zurich,
Switzerland
| $5K | +$5.95K | +4 | +400% |
|
6
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $2K | – | – | – |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$4K | -3 | Closed |
|
GRCE Hedge Fund Activity: Q3 2013 in Review
6 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q3 2013, worth a combined $1.11M — up 11,020% from $10K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GRCE positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Bank of Montreal, opening a new position worth an estimated $891K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $4K sold.
- 6 institutional investors held Grace Therapeutics (GRCE) as of Q3 2013, up from 4 in Q2 2013.
- Funds reported $1.11M of Grace Therapeutics stock for Q3 2013, up 11,020% quarter-over-quarter.
- 3 funds opened new Grace Therapeutics positions in Q3 2013 and 1 closed out, a net change of +2 holders.
- The largest Grace Therapeutics buyer in Q3 2013 was Bank of Montreal, an estimated $891K added.
- The largest Grace Therapeutics seller in Q3 2013 was Tower Research Capital (TRC), an estimated $4K sold.
Based on aggregated 13F filings for Q3 2013.